AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 171 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $235,000 | -53.0% | 3,051 | -59.3% | 0.01% | -70.0% |
| Q3 2017 | $500,000 | +59.2% | 7,498 | +39.4% | 0.02% | +33.3% |
| Q1 2017 | $314,000 | -48.4% | 5,379 | -42.6% | 0.02% | -40.0% |
| Q4 2015 | $609,000 | +102.3% | 9,376 | +119.5% | 0.02% | +150.0% |
| Q3 2015 | $301,000 | -58.0% | 4,271 | -33.7% | 0.01% | -52.4% |
| Q2 2015 | $716,000 | – | 6,443 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |